Intravenous Remifentanil Analgaesia for an Obstetric Patient with Type I Neurofbromatosis and a Factor V Leiden Mutation

Journal Title: Sultan Qaboos University Medical Journal - Year 2017, Vol 17, Issue 4

Abstract

Type I neurofbromatosis is characterised by altered skin pigmentation and the growth of benign tumours, particularly along the peripheral nerves and central nervous system. We report a 36-year-old primigravida woman in labour who was admitted to the obstetric suite of the Hospital Sant Joan de Déu, Barcelona, Spain, in 2007 with hypothyroidism, type I neurofbromatosis and a factor V Leiden mutation. Due to a lack of cranial and spinal imaging data, an epidural was not indicated; instead, continuous intravenous remifentanil analgaesia was administered. Te remifentanil infusion was self-titrated by the patient using a visual analogue scale, with the dosage ranging from 0.01 to 0.25 μg/kg/minute. Due to rotational dystocia, Kjelland-type forceps were used during the delivery. After birth, the infant was found to have Apgar scores of 9 and 10, with no maternal or neonatal adverse effects observed. Although still controversial, remifentanil may be a successful alternative for analgaesia in similar cases; however, the specifc risks and benefts for each patient should be considered prior to administration.

Authors and Affiliations

José L. Gálvez| Department of Anaesthesiology, Resuscitation & Pain Therapeutics, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain, Carlos L. Errando| Departments of Surgical Services and Anaesthesiology, Resuscitation & Pain Therapeutics, Consorcio Hospital General Universitario de Valencia, Valencia, Spain, Silvia Serrano| Department of Anaesthesiology, Resuscitation & Pain Therapeutics, Hospital Sant Joan de Déu, Barcelona, Spain, Marga Martín-Ayuso| Department of Anaesthesiology, Resuscitation & Pain Therapeutics, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain, José M. Valverde-Mantecón| Department of Anaesthesiology, Resuscitation & Pain Therapeutics, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain

Keywords

Related Articles

Assessment Methods in Undergraduate Medical Education

Various assessment methods are available to assess clinical competence according to the model proposed by Miller. Te choice of assessment method will depend on the purpose of its use: whether it is for summative purpos...

Factors Affecting Smoking Initiation and Cessation Among Saudi Women Attending Smoking Cessation Clinics

Objectives: Smoking is one of the most adaptable risk behaviours associated with increased mortality rates, yet over one billion individuals worldwide are smokers. This study aimed to examine self-reported reasons for st...

Shigellosis Outbreak in Al Batinah South Governorate, Oman Case-control study

Objectives: An outbreak of acute gastroenteritis due to Shigella flexneri occurred in August 2012 in the catchment area of the Wadi Sahtan Health Center in Rustaq, Al Batinah South Governorate, Oman. Te aim of this st...

Re: The Effect of Change in Posture on Spirometry in Patients with Obstructive Sleep Apnoea Syndrome

I read with great interest the original study by Al Lawati et al. published in the November 2019 issue of SQUMJ.1 Among a cohort of Omani obstructive sleep apnoea syndrome patients, the authors nicely compared spirometr...

Download PDF file
  • EP ID EP14827
  • DOI 10.18295/squmj.2017.17.04.016
  • Views 331
  • Downloads 17

How To Cite

José L. Gálvez, Carlos L. Errando, Silvia Serrano, Marga Martín-Ayuso, José M. Valverde-Mantecón (2017). Intravenous Remifentanil Analgaesia for an Obstetric Patient with Type I Neurofbromatosis and a Factor V Leiden Mutation. Sultan Qaboos University Medical Journal, 17(4), 468-471. https://europub.co.uk/articles/-A-14827